BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24282897)

  • 1. Uterine sarcoma after tamoxifen therapy for breast cancer.
    Samuji M; O'Sullivan R; Shireen R
    Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
    Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
    Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
    Fisher B; Dignam J; Wolmark N; Wickerham DL; Fisher ER; Mamounas E; Smith R; Begovic M; Dimitrov NV; Margolese RG; Kardinal CG; Kavanah MT; Fehrenbacher L; Oishi RH
    Lancet; 1999 Jun; 353(9169):1993-2000. PubMed ID: 10376613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma.
    Nakhlis F; Lazarus L; Hou N; Acharya S; Khan SA; Staradub VL; Rademaker AW; Morrow M
    J Am Coll Surg; 2005 Nov; 201(5):688-94. PubMed ID: 16256910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?].
    Ivanova OA; Zhil'tsova EK; Barash NIu; Ivanov VG; Ermachenkova AM
    Vopr Onkol; 2011; 57(5):601-3. PubMed ID: 22238929
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen in ductal carcinoma in situ.
    Daly MB
    Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
    Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
    Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcoma associated with tamoxifen use: case report.
    Martin-Loeches M; Rius J; Orti RM
    Eur J Gynaecol Oncol; 2003; 24(2):202-3. PubMed ID: 12701980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].
    Protasova AÉ; Raskin GA; Orlova RV; Protasov DA; Tiukavina NV
    Vopr Onkol; 2011; 57(5):675-9. PubMed ID: 22238943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine sarcoma associated with tamoxifen use.
    Wysowski DK; Honig SF; Beitz J
    N Engl J Med; 2002 Jun; 346(23):1832-3. PubMed ID: 12050351
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.
    Ohara N; Kobayashi A
    J Obstet Gynaecol; 2002 Sep; 22(5):572-3. PubMed ID: 12521448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.